Vista, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Mindera Health, a leader in precision medicine for dermatological conditions, today announced a strategic partnership with the National Psoriasis ...
The following is a summary of “Identification of risk factors associated with metabolic dysfunction-associated steatotic liver disease in psoriatic patients,” published in the November 2024 issue of ...
PM ET Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin ...
Cannabinol modulates distinct endocannabinoid system elements and exerts anti-inflammatory effectsSupports therapeutic ...
Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the Investigator's Global ...
If you're dealing with chronic skin conditions, such as eczema or psoriasis, your skin is more vulnerable to environmental changes so you might also be more likely to get itchy skin during chilly ...
Johnson & Johnson (J&J) has reported positive topline outcomes from its Phase III ICONIC-LEAD trial of oral icotrokinra ...
As Delhi’s AQI hits a new high, it is essential to know the effect it can have on our skin. Know the preventive measures from ...
The once-daily pill, icotrokinra, was tested in patients with moderate-to-severe plaque psoriasis, a skin condition that ...
Advancements in technology, particularly in the realm of electronic skincare devices, are significantly contributing to market expansion. As a result, companies are leveraging strategies such as ...
Diabetes mellitus is a common, chronic metabolic disease that affects a variety of organs including the skin, the largest organ in the body. Between 30 and 70 percent of people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback